Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice

Authors

Angie C.A. Chiang, Baylor College of Medicine
Stephanie W. Fowler, Baylor College of Medicine
Ricky R. Savjani, Texas A&M Health Science Center
Susan G. Hilsenbeck, Baylor College of Medicine
Clare E. Wallace, Washington University School of Medicine in St. Louis
John R. Cirrito, Washington University School of Medicine in St. Louis
Pritam Das, Mayo Clinic Florida
Joanna L. Jankowsky, Baylor College of Medicine

Journal

Journal of Experimental Medicine

Publication Date

2018

Volume

215

Issue

5

First Page

1349

Last Page

1364

Document Type

Open Access Publication

DOI

10.1084/jem.20171484

Rights and Permissions

Chiang ACA, Fowler SW, Savjani RR, Hilsenbeck SG, Wallace CE, Cirrito JR, Das P, Jankowsky JL. Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med. 2018 May 7;215(5):1349-1364. doi: 10.1084/jem.20171484. Epub 2018 Apr 6. © 2018 Chiang et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).

Recommended Citation

Chiang, Angie C.A.; Fowler, Stephanie W.; Savjani, Ricky R.; Hilsenbeck, Susan G.; Wallace, Clare E.; Cirrito, John R.; Das, Pritam; and Jankowsky, Joanna L., "Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice." Journal of Experimental Medicine. 215, 5. 1349 - 1364. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/8514